Utilization patterns of Pulmicort in real life practice
Study identifier:NIS-RES-PUL-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Utilization patterns of Pulmicort HFA in real life practice
Medical condition
asthma
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
260
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Jan 2008
Primary Completion Date: -
Study Completion Date: 01 Feb 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2010 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Asthmatic patients with a diagnose of at least 12 months of duration before study inclusion, previously treated with Pulmicort chlorofluorocarbons (CFC) who have changed their treatment to Pulmicort HFA | - |
Contacts
Investigators
Principal Investigator
Javier Nuevo Rivero
AstraZeneca MC SpainEpidemiologyValue Demonstration Unit
